Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
Spry review
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders, no contracts, a claimed ~24-hour NP review, and no live video visit described anywhere in the flow — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. That combination — real speed and a named founding team, next to an overstated regulatory badge and thin disclosure elsewhere — is why Spry lands in the middle of the pack rather than near the top on this site's Rx-Readiness scorecard.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Spry at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Not disclosed
- Start
- ~24 hours (NP review, per Spry's own claim)
How we scored Spry
Each factor is read off Spry's published pricing, disclosures and intake flow, and the six roll up into the 69/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Claimed ~24-hour NP review, faster than most reviewed, though unverified by direct observation.
Both prices are disclosed, but confirmed only via the compiled JS bundle rather than the visible page.
No live video visit described anywhere in the published flow.
No state list disclosed anywhere checked.
Semaglutide and tirzepatide on one account — switch without re-signing.
No contracts required, per Spry's own claim, though no formal refund policy was found.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- becomespry.com
$199 and $299, confirmed from the site's compiled code since the pages render nothing. One flag: an 'FDA Approved' badge sits over compounded medications, which aren't FDA-approved products. No state list.
What to expect when you sign up
We walked Spry's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1becomespry.com is a client-rendered app — pricing was confirmed by pulling and reading its actual JS bundle, not just the marketing page
- 2Three co-founders are named on-site: Gabriel Mullins, Sara Yoder, and Tyler Bowman
- 3No contracts required; a nurse practitioner reviews intake within roughly 24 hours per Spry's own claims
- 4No live video visit is described anywhere in the published flow
What we noticed
- Spry's homepage displays an 'FDA Approved' badge and 'FDA-approved treatments' copy — but compounded semaglutide and tirzepatide are not themselves FDA-approved finished drug products
- A stated ~24-hour NP review is one of the faster claimed turnarounds reviewed, though it's a marketing claim rather than something independently timed
- No state-availability list found, and no pharmacy is named beyond generic language
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideStarting tierConfirmed live by pulling Spry's own JS bundle (becomespry.com is a client-rendered app). | $199 | Starting tierConfirmed live by pulling Spry's own JS bundle (becomespry.com is a client-rendered app). |
| Compounded tirzepatideStarting tierConfirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, left out of these rows. | $299 | Starting tierConfirmed the same way. Spry also sells three longevity peptides (BPC-157, NAD+, sermorelin) at $249-$299/mo — not GLP-1s, left out of these rows. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are Spry's public disclosures at last review and change often; confirm the current number on Spry's own site.
What we like
- Claimed ~24-hour NP review with no live video visit described in the flow
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Site is a client-rendered app, which made its own pricing harder to verify than a normal marketing page
Spry for working moms: our verdict
$199/mo semaglutide, $299/mo tirzepatide, three named co-founders, no contracts, a claimed ~24-hour NP review, and no live video visit described anywhere in the flow — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. That combination — real speed and a named founding team, next to an overstated regulatory badge and thin disclosure elsewhere — is why Spry lands in the middle of the pack rather than near the top on this site's Rx-Readiness scorecard. It runs about $199/month.
We weigh Spry the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What Spry will cost you
- Compounded semaglutide — Starting tier: $199/mo
- Compounded tirzepatide — Starting tier: $299/mo
That's roughly in line with the ~$179/month median across our roster.
The medications Spry prescribes
Spry prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Spry fits — and where it doesn't — for working moms
Right for you if…
- you want a straightforward semaglutide and tirzepatide program and will confirm the details before you commit.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Spry is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: A working mom who wants a fast, fully-online start and named founders behind the brand, and will read the 'FDA Approved' badge skeptically rather than at face value.
Alternatives to Spry
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing Spry
Head-to-head & alternatives
Spry, answered
- How much does Spry cost?
- Budget around $199 a month — that was Spry's lowest ongoing compounded rate at last review ($199/mo semaglutide, $299/mo tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start Spry without a scheduled video visit?
- Spry involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does Spry offer both semaglutide and tirzepatide?
- Yes — Spry offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does Spry rank for working moms?
- Spry earns 69/100 on our Rx-Readiness Score, ranking #53. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect Spry's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.